Global coalition calls for stronger government action on COPD
Joint Declaration, Speak Up for COPD coalition, UNITE Parliamentarians Network for Global Health
A global coalition of patient advocates, industry and non-profit organisations has called on governments to strengthen action on chronic obstructive …
Global health researchers call for more equitable partnerships
September 17, 2026Equitable Partnerships in Global Health Research, Global Consortium for Public Health Research, University of Huddersfield, infectious disease, social inequalities
More than 70 academics, researchers, public health professionals, policymakers and research partners from around the world have called for greater …
Liverpool launches £20m lab for infectious disease drug discovery
September 16, 2026AI, human organoids, infectious disease drug discovery lab, liverpool, robotics
A new £20m high-security laboratory using robotics, artificial intelligence (AI) and human organoids to accelerate drug and vaccine development for …
Circle Health Group expands into UK laboratory operations
September 15, 2026Circle Health Group, PureHealth, UK laboratory operations, diagnostic services
Circle Health Group (Circle) has expanded into laboratory operations across the UK through the acquisition of selected laboratory operations from …
FibroFind appoints Professor Andrew Fisher as Chief Medical Officer
September 14, 2026FibroFind
FibroFind, a preclinical Contract Research Organization (CRO) specialising in human-relevant tissue models, has appointed Professor Andrew Fisher as Chief Medical …
Pharma sees climate disruption as growing supply-chain risk
September 11, 2026British Standards Institution, climate disruption, pharma, supply-chain risk
Nine in ten pharmaceutical companies across the UK and G7 countries expect climate-related disruption to their supply chains to increase …
Manchester NHS-MHRA partnership to test new technologies in real-world care
September 10, 2026AI-enabled medical devices, Manchester, NHS-MHRA partnership, patient care
Patients in Manchester could gain faster access to promising healthcare technologies through a new partnership between the Medicines and Healthcare …
Ondine reports 40% reduction in surgical-site infections in phase 3 trial
September 9, 2026Ondine Biomedical, nasal photodisinfection technology, phase 3 trial, surgical-site infections
Ondine Biomedical has reported a 40% relative reduction in 30-day surgical-site infections (SSIs) in a 5,188-patient phase 3 trial of …
Northern Ireland to roll out staff well-being training across health service
September 8, 2026Northern Ireland Health and Social Care, staff well-being training
Thousands of line managers across Northern Ireland’s Health and Social Care (HSC) system are to receive new training designed to …
European consortium demonstrates continuous manufacturing platform for pharmaceutical ingredients
September 7, 2026European PIPAC consortium, continuous manufacturing platform, supply-chain resilience
A European consortium has demonstrated a continuous manufacturing platform for pharmaceutical active ingredients (APIs), combining continuous-flow chemistry, real-time analytical monitoring …
From lab breakthrough to NHS treatment: Getting innovative therapies to patients
September 5, 2026Clinical trials supplies & documentation logistics, Due Diligence, NICE / SMC Submissions, Pharmacovigilance, Regulatory Affairs Oncology
By Chloe Williams and Sarah Ellson Innovative therapies are transforming the treatment landscape for serious diseases, particularly cancer. Advances in …
Five Facts about NHS and primary care
September 5, 2026Medical Communications Five Facts, HRT, NHS, primary care
1 Primary care is the front door to the NHS, but it extends well beyond general practice. It includes primary …
Clinical trials don’t just have a recruitment problem, they have an enrolment protection problem.
September 5, 2026Clinical & Scientific, Clinical Research, Clinical Trial Services, Clinical research Training, Clinical trial specialist packaging, Data Capture Asthma & COPD, Chronic Diseases, Immunology, Rare Diseases, Sample integrity, clinical trials, enrolment
By Dr. Richard Graham Industry conversations about clinical trial participation tend to focus on awareness, access, and willingness to enrol. …
AI in pharma: From lab development to patient impact
September 5, 2026AI, Cancer, Immunology, Merck, Vaccine, Virology, personalised medicine, pharma
In the decade to 2025, AI use in vaccine development has increased markedly but is the boom in research translating …
Back to basics: X-ray inspection in pharmaceutical and medical device production
September 5, 2026Licences/Quality Standards, Packaging, Pharmacovigilance Contamination Control, Devices, inspection, pharmaceutical manufacturing, regulatory
By Adam Green In pharmaceutical manufacturing, inspection plays a critical role in process control to examine individual products, primary packs, …
Power of partnership: Turning shared purpose into improved shared decision-making in rare disease
September 5, 2026Internal Communication Campaigns, Market Access Consultancy, Medical Communications, Medical Communications Training, Patient Advocacy Rare Diseases, ZPB Associates
In February 2026, PMGroup Worldwide Ltd and Visions4Health launched the Excellence in Healthcare Partnerships (EHP) Awards to recognise innovative collaborations …
Major funding opportunity opens for early cancer diagnostics
September 4, 2026Innovate UK, NHS, Scotland, cancer research funding
Up to £25.4m in funding is available for collaborative projects developing technologies to improve the early detection and diagnosis of …
Androlabs receives UK authorisation for new Testavan presentation
September 4, 2026Androlabs, Testavan, UK authorisation, hypogonadism, testosterone
Androlabs has received UK marketing authorisation for a new presentation of Testavan 4.6 mg/actuation transdermal gel for testosterone replacement therapy …
CEPI backs African-led Bundibugyo Ebola vaccine development
September 3, 2026Africa, CEPI, Ebola vaccine
Minapharm Group is to receive up to US$16.5m from the Coalition for Epidemic Preparedness Innovations (CEPI) to advance development of …
Cytomos appoints life sciences executive to board
September 2, 2026Alex Jones, Cytomos, non-executive director
Edinburgh-based biotechnology company Cytomos has appointed life sciences executive Dr Alex Jones as a non-executive director as it moves to …
Cell therapy partnership aims to bring liver disease treatment closer to US patients
September 1, 2026Resolution Therapeutics, US, cell therapy, liver disease
Resolution Therapeutics has partnered with the Blood Centers of America (BCA) to support community-based delivery of its experimental cell therapy …
Latest content
Global coalition calls for stronger government action on COPD
Global health researchers call for more equitable partnerships
Liverpool launches £20m lab for infectious disease drug discovery
Circle Health Group expands into UK laboratory operations
FibroFind appoints Professor Andrew Fisher as Chief Medical Officer
